Skip to content

Cyanoacrylate Versus Omentum for Staple-Line Reinforcement in Sleeve Gastrectomy

Cyanoacrylate Versus Omentum for Enforcement of the Staple Line in Sleeve Operation

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07339020
Enrollment
70
Registered
2026-01-14
Start date
2025-06-20
Completion date
2026-05-14
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Bariatric surgery, Cyanoacrylate, Glubran, Laparoscopic sleeve gastrectomy, Omentopexy, Staple Line Reinforcement, Postoperative Hemorrhage, Surgical Leak

Brief summary

Study Title: Comparing Surgical Glue (Cyanoacrylate) vs. Omentum Tissue to Strengthen Staple Lines in Weight-Loss Sleeve Surgery What is the purpose of this study? This study will compare two ways to strengthen the staple line during weight-loss sleeve surgery. One way uses a medical glue called cyanoacrylate, and the other uses a piece of tissue from the abdomen called omentum. The goal is to see which method works better to lower the chance of bleeding, pain, or leaks after surgery. Who can take part? Adults ages 18-65 who: * Have a body mass index (BMI) over 35, or over 30 if they also have health problems related to obesity. * Are scheduled to have weight-loss sleeve surgery at Cairo University Hospital. Participants cannot take part if they: * Are younger than 18 or older than 65. * Have had weight-loss surgery before. What will happen in the study? * Participants will be assigned by chance to one of two groups: 1. Glue group: The staple line will be sealed with medical glue. 2. Omentum group:The staple line will be covered and sewn with a piece of the body's own tissue. * Everyone will have the same type of surgery and be cared for in the same way afterward. * Participants will be monitored closely for one month after surgery to check for problems like bleeding, pain, or leaks. * Follow-up visits will happen within one week after surgery and again at one month. What are the possible risks? The risks are low and similar to those of regular weight-loss surgery. Some people may feel pain or anxiety after surgery. The study team will watch for any problems and treat them right away. Why is this study being done? Weight-loss sleeve surgery is common, but sometimes the staple line can leak or bleed. Finding a better way to strengthen it may help people recover more safely and with less pain. How long will the study last? The study will take about six months to complete, including surgery and follow-up. Who is running the study? The study is being done by doctors in the General Surgery Department at Cairo University's Faculty of Medicine.

Interventions

DEVICEGlubran® 2 surgical glue (n-butyl-2-cyanoacrylate mixture) and its specific applicator.

A synthetic surgical adhesive applied to the staple line for reinforcement and hemostasis using its proprietary delivery applicator.

BIOLOGICALAutologous Greater Omentum

pedicled flap of the patient's own greater omentum sutured over the staple line for reinforcement using a PDS 2/0 round needle suture.

PROCEDUREStaple Line Reinforcement during Laparoscopic Sleeve Gastrectomy

Reinforcement of the gastric staple line during laparoscopic sleeve gastrectomy.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Cases underwent LSG with age ≥18 years old and ≤65 years old and BMI ≥35 or ≥30 with comorbid disease related to obesity. * Candidate for Laparoscopic Sleeve Gastrectomy

Exclusion criteria

* Cases underwent previous bariatric surgery. * Multiple Extensive previous surgeries. * Crohn's Disease. * Elderly patients with extensive comorbidities * Severe gastroesophageal reflux disease (GERD) * Severe Bleeding disorders * Psychiatric illness or cognitive impairment affecting consent or compliance

Design outcomes

Primary

MeasureTime frameDescription
Comparison of Staple Line Complications After Sleeve Gastrectomy: Glubran vs. OmentumFrom surgery up to 30 days postoperativelyThis measure compares two methods of staple line reinforcement during laparoscopic sleeve gastrectomy to see which works better at preventing complications within the first 30 days after surgery. The complications of interest are postoperative leakage (staple line leak), bleeding requiring intervention, and abdominal pain. Patients are randomly assigned to have their staple line reinforced either with medical glue (cyanoacrylate) or with the patient's own fatty tissue (omentum).

Secondary

MeasureTime frameDescription
Comparison of Operative Time Between Reinforcement MethodsMeasured on the day of surgery.This measure compares the total surgical time (in hours) from skin incision to closure between the two study groups: cyanoacrylate glue reinforcement vs. omentum reinforcement.
Length of Hospital Stay After Sleeve GastrectomyFrom surgery until discharge, assessed up to 30 days postoperatively.This measure compares the number of days patients stay in the hospital after surgery between the two reinforcement groups, from the day of surgery until discharge.
Economic Cost of Reinforcement MaterialsAssessed on the day of surgeryThis measure compares the direct cost of the reinforcement materials used in each group: cyanoacrylate glue versus omentum
Incidence of Delayed Staple Line ComplicationsFrom discharge up to 30 days postoperatively.This measure assesses whether any staple line complications (such as delayed leakage or bleeding) occur after discharge, within the first month post-surgery.
Rate of Hospital Readmission Within 30 DaysWithin 30 days after discharge.This measure compares the proportion of patients in each group who are readmitted to the hospital within 30 days after discharge due to any surgery-related complication.
Rate of Reoperation Within 30 DaysWithin 30 days postoperatively.This measure compares the proportion of patients in each group who require a second surgical intervention (reoperation) within 30 days after the initial surgery due to complications such as bleeding, leakage, or hematoma.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 19, 2026